Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: A prospective cohort study

Atherosclerosis

Volumn 240, Issue 1, 2015, Pages 144-148

  Zhang, Tao ^a   Zhang, Chengqi ^b   Zhang, Yongyuan ^c   Tang, Fang ^b   Li, Hongkai ^a   Zhang, Qian ^a   Lin, Haiyan ^d   Wu, Shuo ^a   Liu, Yanxun ^a   Xue, Fuzhong ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Metabolic syndrome; Non alcoholic fatty liver disease; Prospective cohort

Indexed keywords

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIET; DIETARY INTAKE; EXERCISE; FEMALE; FOLLOW UP; HAN CHINESE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEAT; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEA FOOD; SEX DIFFERENCE; SMOKING; URBAN POPULATION; VEGETARIAN; ASIAN CONTINENTAL ANCESTRY GROUP; CHI SQUARE DISTRIBUTION; CHINA; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; HEALTH; HYPERLIPIDEMIAS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; URBAN HEALTH;

EID: 84924660838     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.02.049     Document Type: Article

References (30)

1. Angulo P. Nonalcoholic fatty liver disease. N.Engl. J. Med. 2002, 346(16):1221-1231.
2. Hamaguchi M., Kojima T., Takeda N., et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J. Gastroenterol. 2007, 13(10):1579-1584.
3. Tarantino G., Finelli C. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome. World J. Gastroenterol. 2013, 19(22):3375-3384.
4. Almeda-Valdes P., Cuevas-Ramos D., Aguilar-Salinas C.A. Metabolic syndrome and non-alcoholic fatty liver disease. Ann. Hepatol. 2009, (8 Suppl.1):S18-S24.
5. Tsai C.H., Li T.C., Lin C.C. Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease. South Med. J. 2008, 101(9):900-905.
6. Hamaguchi M., Takeda N., Kojima T., et al. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J. Gastroenterol. 2012, 18(13):1508-1516.
7. Mohan V., Farooq S., Deepa M., Ravikumar R., Pitchumoni C.S. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res. Clin. Pract. 2009, 84(1):84-91.
8. Graham R.C., Burke A., Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J.Pediatr. Gastroenterol. Nutr. 2009, 49(4):442-449.
9. Castro-Martinez M.G., Banderas-Lares D.Z., Ramirez-Martinez J.C. Escobedo-de lPJ. Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome. Cir. Cir. 2012, 80(2):128-133.
10. Hamaguchi M., Kojima T., Takeda N., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern Med. 2005, 143(10):722-728.
11. Fan J.G., Farrell G.C. Epidemiology of non-alcoholic fatty liver disease in China. J.Hepatol. 2009, 50(1):204-210.
12. Fan J.G., Zhu J., Li X.J., et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J.Hepatol. 2005, 43(3):508-514.
13. Li Z., Xue J., Chen P., Chen L., Yan S., Liu L. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J.Gastroenterol. Hepatol. 2014, 29(1):42-51.
14. Chitturi S., Farrell G.C., Hashimoto E., Saibara T., Lau G.K., Sollano J.D. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J.Gastroenterol. Hepatol. 2007, 22(6):778-787.
15. Zeng M.D., Fan J.G., Lu L.G., et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J.Dig. Dis. 2008, 9(2):108-112.
16. Lu Y.H., Lu J.M., Wang S.Y., et al. Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch. Zhonghua Yi Xue Za Zhi 2006, 86(6):386-389.
17. Schunk D.A. Markov chain Monte Carlo algorithm for multiple imputation in large surveys. AStA Adv. Stat. Anal. 2008, 92(1):101-114.
18. Fabbrini E., Sullivan S., Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010, 51(2):679-689.
19. Jornayvaz F.R., Samuel V.T., Shulman G.I. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu Rev. Nutr. 2010, 30:273-290.
20. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366(9491):1059-1062.
21. Oh S.W., Park C.Y., Lee E.S., et al. Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res. 2011, 13(2):R34.
22. Rector R.S., Thyfault J.P., Laye M.J., et al. Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. J.Physiol. 2008, 586(Pt 17):4241-4249.
23. Angelico F., Del B.M., Conti R., et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J.Clin. Endocrinol. Metab. 2005, 90(3):1578-1582.
24. Tilg H., Moschen A.R. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol. Metab. TEM 2008, 19(10):371-379.
25. Puri P., Baillie R.A., Wiest M.M., et al. Alipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007, 46(4):1081-1090.
26. Ferrannini E., Cushman W.C. Diabetes and hypertension: the bad companions. Lancet 2012, 380(9841):601-610.
27. Zhang T., Zhang Y., Zhang C., et al. Prediction of metabolic syndrome by non-alcoholic Fatty liver disease in northern urban han Chinese population: a prospective cohort study. PLoS One 2014, 9(5):e96651.
28. Athyros V.G., Mikhailidis D.P., Didangelos T.P., et al. Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. Curr. Med. Res. Opin. 2006, 22(5):873-883.
29. Gill H.K., Wu G.Y. Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer. World J. Gastroenterol. 2006, 12(3):345-353.
30. Zivkovic A.M., German J.B., Sanyal A.J. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am. J. Clin. Nutr. 2007, 86(2):285-300.